ADC Therapeutics S.A.

ADCT· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$1.54+0.98%

2026-11-02

Financials

Valuation Metrics

ADC Therapeutics S.A.'s Market Cap is $197M. At end of 2025 it was $531M. Ranked #2994 of 3,116 in US market (top 96%), #1623 of 1,644 on NYSE (top 99%), #248 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 94%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$197M	US#2,994/3,116 Sec#248/265
Revenue	$79M	US#2,706/3,116 Sec#131/265
Net Income	$-97M	US—/3,116 Sec—/265
Total Assets	$279M	US#2,922/3,116 Sec#216/265
Net Assets	$-228M	US#2,984/3,116 Sec#258/265
Value
P/S	2.49x	US#1,464/3,116 Sec#39/265
FCF Yield	-52.07%	US—/3,116 Sec—/265
Profitability
ROA	-34.69%	US#2,912/3,116 Sec#173/265
Op. Margin	-125.83%	US#2,723/3,116 Sec#127/265
Revenue Growth	1.97%	US#2,036/3,116 Sec#124/265
Financial Health
Total Debt	$417M	US#1,955/3,116 Sec#67/265
FCF	$-102M	US#2,635/3,116 Sec#146/265
Cash	$219M	US#1,661/3,116 Sec#102/265
Current Ratio	3.03x	US#768/3,116 Sec#189/265
Performance
1Y Return	-65.36%	US#3,022/3,116 Sec#253/265
1M Return	36.73%	US#197/3,116 Sec#16/265
From 52W High	-68.98%	US#2,983/3,116 Sec#240/265
1Y MDD	-80.33%	US#3,039/3,116 Sec#246/265
Trading
Volume	965,736 shares	US#1,697/3,116 Sec#173/265
Trading Value	$2M	US#2,993/3,116 Sec#249/265
Per Share
EPS	$-0.76	US—/3,116 Sec—/265
BPS	$-1.79	US—/3,116 Sec—/265